Global Sequencing Reagents Market 2024-2028
Sequencing Reagents Market 2024-2028
The sequencing reagents market is forecasted to grow by USD 4106 mn during 2023-2028, accelerating at a CAGR of 12.4% during the forecast period. The report on the sequencing reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing affordability of dna sequencing, growing demand for early diagnosis of genetic disorders, and expanding applications of dna sequencing.
Technavio's sequencing reagents market is segmented as below:
By Technology
- Next-generation sequencing
- Sanger sequencing
- Third generation sequencing
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advances in next generation sequencing techniques as one of the prime reasons driving the sequencing reagents market growth during the next few years. Also, development of sophisticated bioinformatics tools for next generation sequencing and automation of dna sequencing will lead to sizable demand in the market.
The report on the sequencing reagents market covers the following areas:
- Sequencing Reagents Market sizing
- Sequencing Reagents Market forecast
- Sequencing Reagents Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sequencing reagents market vendors that include Agilent Technologies Inc., BGI Group, BioChain Institute Inc., F. Hoffmann La Roche Ltd., Fluidigm Corp., FroggaBio Inc., Illumina Inc., LGC Biosearch Technologies, Merck KGaA, Meridian Bioscience Inc, New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Perkin Elmer Inc., QIAGEN N.V., Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Trilink Biotechnologies. Also, the sequencing reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.